Several mutations in human JPH2 have been associated with hypertrophic cardiomyopathy (Beavers et al., 2014), and can cause a hypertrophyc phenotype when downregulated in mouse cardiac muscle cell lines (Landstrom et al., 2011). Here, JPH2 is linked to hypertrophic cardiomyopathy.